Biotech megarounds ga­lore; New lead­ers at No­var­tis, Bio­gen; State of play for GLP-1 in NASH; In­side Il­lu­mi­na’s CEO search; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

De­spite a short­er week, we still saw biotech news come back in full force for Sep­tem­ber, par­tic­u­lar­ly on the fi­nanc­ing and peo­ple front — with Il­lu­mi­na fi­nal­ly mak­ing its CEO pick, in ad­di­tion to No­var­tis and Bio­gen nam­ing new lead­ers as part of a big­ger vi­sion. At End­points, we were ex­cit­ed to wel­come Ay­isha Shar­ma to the Lon­don team.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.